Travelers Companies, INC Form 4 insider transactions
NYSE
Travelers EVP Michael Klein reported the acquisition of over 21,000 shares from performance awards and a subsequent sale of 10,000 shares for tax purposes.
NYSE
Travelers Chairman and CEO Alan Schnitzer reported the acquisition of common stock from performance share rights and a subsequent disposition for tax withholding.
NYSE
Travelers Companies' Vice Chairman and Chief Legal Officer, Avrohom J. Kess, acquired common stock through performance share rights and subsequently sold a portion to cover tax liabilities.
NYSE
Travelers' EVP and Chief Risk Officer Maria Olivo reported the vesting of performance-based common stock and a subsequent sale to cover tax obligations.
NYSE
Travelers Companies Vice Chairman William H. Heyman reported multiple transactions in company common stock, including option exercises, sales, and performance share awards.
NYSE
Travelers Companies, Inc. EVP & CFO Daniel S. Frey reported the vesting of performance share rights and a subsequent tax-related sale of common stock.
NYSE
Paul E. Munson, SVP & Corporate Controller of Travelers Companies, Inc., reported the vesting of performance-based common stock and a subsequent tax-related disposition.
NYSE
Travelers' EVP & Chief HR Officer, Diane Kurtzman, reported the acquisition of common stock from performance awards and a subsequent disposition for tax purposes.
NYSE
A Travelers Companies executive reported exercising stock options and subsequently selling a portion of the acquired shares, alongside receiving performance-based stock.
NYSE
Travelers Companies EVP Jeffrey P. Klenk reported the acquisition of common stock from performance share vesting and a subsequent disposition for tax purposes.
NYSE
Travelers' EVP and Chief Risk Officer, Maria Olivo, exercised stock options and immediately sold the acquired shares on February 6, 2026.
NYSE
Travelers EVP Michael Klein exercised stock options and subsequently sold 10,000 shares of common stock.
NYSE
Travelers Companies, Inc. Vice Chairman William H. Heyman executed pre-planned transactions, exercising stock options and selling shares.
NYSE
Paul E. Munson, SVP & Corp. Controller at Travelers, acquired 1,165 stock options with an exercise price of $288.23.
NYSE
Diane Kurtzman, EVP & Chief HR Officer at Travelers Companies, Inc., acquired 6,060 stock options with an exercise price of $288.23.
NYSE
Mojgan M Lefebvre, EVP & Chief Tech & Ops Officer at Travelers, acquired 10,651 stock options with an exercise price of $288.23.
NYSE
Maria Olivo, EVP, ERM & Chief Risk Officer at Travelers, was granted 10,773 stock options with an exercise price of $288.23.
NYSE
Jeffrey P. Klenk, EVP & President of Bond & Specialty Insurance at Travelers, acquired 12,854 stock options with an exercise price of $288.23.
NYSE
David Donnay Rowland, EVP & Co-Chief Investment Officer at Travelers Companies, Inc., acquired 7,407 stock options with an exercise price of $288.23.
NYSE
Michael Frederick Klein, EVP & President of Personal Insurance at Travelers, acquired 16,649 stock options under a Rule 10b5-1 plan.
NYSE
Travelers Companies, Inc. EVP & Chief Financial Officer Daniel S. Frey reported the acquisition of 13,026 stock options.
NYSE
Daniel Tei-Hwa Yin, EVP & Co-Chief Investment Officer at Travelers, acquired 7,407 stock options with an exercise price of $288.23.
NYSE
Travelers EVP & President, Business Insurance, Gregory C. Toczydlowski, was granted 17,629 stock options with an exercise price of $288.23.
NYSE
Travelers Companies Chairman and CEO Alan D. Schnitzer exercised stock options and subsequently sold a portion of his shares, as disclosed in a recent SEC Form 4 filing.
NYSE
Travelers Companies EVP and Chief Admin Officer Andy F. Bessette was granted 6,427 stock options with an exercise price of $288.23.
NYSE
Travelers Companies' Vice Chairman and Chief Legal Officer, Avrohom J. Kess, was granted 14,691 stock options.
NYSE
Travelers Companies director David Scott Williams acquired 729 deferred stock units valued at $288.23 per unit, increasing his beneficial ownership.
NYSE
Travelers Companies Director Bridget A van Kralingen acquired 729 deferred stock units at $288.23 per unit, increasing her beneficial ownership to 4,622.338 shares.
NYSE
Travelers Companies Director Elizabeth Robinson acquired 729 deferred stock units, increasing her direct beneficial ownership to 12,186.626 shares.
NYSE
Travelers Companies Director Clarence Otis Jr. acquired 729 deferred stock units valued at $288.23 each, increasing his beneficial ownership.